Ronald Blue Trust, Inc. Myriad Genetics Inc Transaction History
Ronald Blue Trust, Inc.
- $7.68 Billion
- Q1 2025
A detailed history of Ronald Blue Trust, Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 14,367 shares of MYGN stock, worth $106,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,367
Previous 9,153
56.96%
Holding current value
$106,315
Previous $125,000
1.6%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MYGN
# of Institutions
229Shares Held
86MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$112 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$78.4 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$40.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$32.2 Million0.03% of portfolio
-
Glenview Capital Management, LLC New York, NY4.16MShares$30.8 Million1.44% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $597M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...